autologous extracellular vesicles from serum
Biologicalexperimental
Clinical trial activity
2 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Sep 18, 2020 (NCT04652531)
Timeline
2020s
- Jan 1, 2024
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06002841 | Phase 1/Phase 2 (Phase 2) | Feb 1, 2024 | D'Or Institute for Research and Education, Federal University of Rio de Janeiro, Hospital Sao Rafael, Oswaldo Cruz Foundation, Rio de Janeiro State University |
| NCT04652531 | N/A | Sep 18, 2020 | University of Turin |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| D'Or Institute for Research and Education | Academic/Hospital | 1 | 1 | 1 | 2024 |
| Federal University of Rio de Janeiro | Academic/Hospital | 1 | 0 | 1 | 2024 |
| Hospital Sao Rafael | Academic/Hospital | 1 | 0 | 1 | 2024 |
| Oswaldo Cruz Foundation | Academic/Hospital | 1 | 0 | 1 | 2024 |
| Rio de Janeiro State University | Academic/Hospital | 1 | 0 | 1 | 2024 |
| University of Turin | Academic/Hospital | 1 | 1 | 1 | 2020 |
6 organizations
Page 1 / 1